Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had revenue of $14.99M in the twelve months ending December 31, 2025, up 2,161.41% year-over-year. In the fiscal year ending June 30, 2025, Neuphoria Therapeutics had annual revenue of $15.65M.

• Revenue (ttm): $14.99M
• Revenue Growth: +2,161.41%
• P/S Ratio: 1.58
• Revenue / Employee: $1,873,342
• Employees: 8
• Market Cap: 23.85M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	15.65M	-	-
Jun 30, 2024	-	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	4.17M	3.48M	499.60%
Jun 30, 2021	695.81K	-1.37M	-66.32%